Publication | Open Access

Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines

Medicinal ChemistryOncogenic AgentMedicineNovel Imidazole DerivativesAnti-cancer AgentCancer TreatmentCytotoxic ActivityPharmacologyRadiation OncologyPharmaceutical ChemistryCancer ResearchDrug Discovery